共 50 条
Effects of Testosterone Supplementation on Separate Cognitive Domains in Cognitively Healthy Older Men: A Meta-analysis of Current Randomized Clinical Trials
被引:27
|作者:
Tan, Sherilyn
Sohrabi, Hamid R.
Weinborn, Michael
Tegg, Michelle
Bucks, Romola S.
Taddei, Kevin
Carruthers, Malcolm
Martins, Ralph N.
机构:
[1] Australian Alzheimers Res Fdn, Nedlands, WA, Australia
[2] Univ Western Australia, Sch Psychol Sci, Perth, WA, Australia
[3] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia
[4] Univ Western Australia, Sch Psychiat & Clin Neurosci, Nedlands, WA, Australia
[5] Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, Australia
[6] Ctr Mens Hlth, London, England
关键词:
Testosterone supplementation;
hypogonadism;
cognitive decline;
ageing;
Alzheimer's disease;
cognitive function;
memory;
ENDOGENOUS SEX-HORMONES;
SERUM-FREE TESTOSTERONE;
LATE-ONSET HYPOGONADISM;
ALZHEIMERS-DISEASE;
ELDERLY-MEN;
ENDOCRINE-SOCIETY;
VISUOSPATIAL COGNITION;
POSITION STATEMENT;
ANDROGEN RECEPTOR;
AGING MEN;
D O I:
10.1016/j.jagp.2019.05.008
中图分类号:
R592 [老年病学];
C [社会科学总论];
学科分类号:
03 ;
0303 ;
100203 ;
摘要:
Background: An increasing body of literature suggests a positive, neuroprotective effect for testosterone on cognition in older men. However, randomized clinical trials (RCTs) examining the effects of testosterone supplementation (TS) on cognitive function have been inconclusive. Objective: To investigate the potential for TS to prevent cognitive decline in otherwise cognitively healthy older men, by examining the differential effects of TS on cognitively healthy older men in RCTs. Methods: Comprehensive search of electronic databases, conference proceedings, and grey literature from 1990 to 2018 was performed to identify RCTs examining the effects of TS on cognition before and after supplementation, in cognitively healthy individuals. Results: A final sample of 14 eligible RCTs met inclusion criteria. Using pooled random effects expressed as Hedge's g, comparison of placebo versus treatment groups pre- and post-supplementation showed improvements in the treatment group in executive function (g (11) = 0.14, 95% confidence interval [CI]: 0.03-0.26, z = 0.56, p = 0.011). However, it was noted that two studies in our sample did not report a significant increase in mean serum total testosterone (TT) levels in the treatmentgroup after supplementation. Following exclusion of these studies, analysis indicated improvement in the treatment group for the overall cognitive composite (g (11) = 0.18, 95% CI: 0.02-0.33, z = 2.18), psychomotor speed (g (3) = 0.22, 95% CI: 0.01-0.43, z = 2.07) and executive function (g (9) = 0.15, 95% CI: 0.03-0.28, z = 2.35). No significant differences were noted for the global cognition, attention, verbal memory, visuospatial ability or visuospatial memory domains. Conclusion: Overall, our findings support the potential for TS as a preventative measure against cognitive decline, although the effect sizes were small. These findings warrant further observational studies and clinical trials of good methodological quality, to elucidate the effect of TS on cognition.
引用
收藏
页码:1232 / 1246
页数:15
相关论文